GENEOS Therapeutics has filed a notice of an exempt offering of securities to raise $9,999,996.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, GENEOS Therapeutics is raising $9,999,996.00 in new funding. Sources indicate that as part of senior management President and Chief Executive Officer, Niranjan Sardesai played a…
